ONE-WAYOngoing theme · still written in the latest filings
Creating treatments using technology that enables previously difficult-to-drug targets
A mission to use PepMetics technology to bring intracellular PPI targets that were previously difficult to drug within the scope of pharmaceutical development, with the aim of creating treatments for diseases for which no treatment currently exists.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.